Adverum Biotechnologies, Inc. (ADVM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 0 | 0 | 3.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.5M | 0 |
| Revenue Growth % | -100% | - | - | - | - | - | -100% | - | - | - | - | - | - | - | -100% | - | - | - | - | - |
| Cost of Goods Sold | 465K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | 83.86% | - | - | - | - | - | - | - | - | - |
| Gross Profit | -465K | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 0 | 0 | 581K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.5M | 0 |
| Gross Margin % | - | - | - | - | 100% | - | - | - | - | - | 16.14% | - | - | - | - | - | - | - | 100% | - |
| Gross Profit Growth % | -146.5% | - | - | - | - | - | -100% | - | - | - | - | - | - | - | -100% | - | - | - | - | - |
| Operating Expenses | 46.56M | 49.85M | 48.22M | 62.22M | 30.22M | 32.9M | 29.2M | 26.16M | 34.53M | 33.06M | 30.82M | 33.94M | 41.04M | 44.02M | 38.13M | 34.42M | 38.52M | 44.54M | 36.14M | 36.38M |
| OpEx % of Revenue | - | - | - | - | 3022.1% | - | - | - | - | - | 856.11% | - | - | - | - | - | - | - | 481.91% | - |
| Selling, General & Admin | 9.11M | 12.73M | 19.47M | 38.12M | 9.78M | 15.81M | 13.79M | 10.88M | 13.79M | 12.47M | 9.76M | 11.74M | 17.19M | 13.76M | 15.17M | 11.89M | 14.45M | 21.93M | 16.16M | 13.65M |
| SG&A % of Revenue | - | - | - | - | 978.2% | - | - | - | - | - | 271.14% | - | - | - | - | - | - | - | 215.51% | - |
| Research & Development | 38.91M | 37.13M | 28.75M | 24.09M | 20.44M | 17.1M | 15.41M | 15.28M | 20.74M | 20.6M | 21.06M | 22.2M | 23.85M | 30.27M | 22.96M | 22.52M | 24.07M | 22.61M | 19.98M | 22.73M |
| R&D % of Revenue | - | - | - | - | 2043.9% | - | - | - | - | - | 584.97% | - | - | - | - | - | - | - | 266.4% | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -47.02M | -49.85M | -48.22M | -62.22M | -29.22M | -32.9M | -29.2M | -26.16M | -34.53M | -33.06M | -30.24M | -33.94M | -41.04M | -44.02M | -38.13M | -34.42M | -38.52M | -44.54M | -28.64M | -36.38M |
| Operating Margin % | - | - | - | - | -2922.1% | - | - | - | - | - | -839.97% | - | - | - | - | - | - | - | -381.91% | - |
| Operating Income Growth % | -60.92% | -51.52% | -65.15% | -137.85% | 15.37% | 0.49% | 3.44% | 22.93% | 15.86% | 24.89% | 20.7% | 1.39% | -6.53% | 1.15% | -33.13% | 5.39% | -37.56% | -49.58% | -20.39% | -85.11% |
| EBITDA | -46.56M | -49.32M | -47.54M | -61.41M | -28.33M | -31.95M | -28.2M | -25.15M | -33.02M | -31.53M | -27.22M | -32.23M | -39.25M | -42.42M | -36.71M | -33.1M | -37.56M | -43.34M | -27.48M | -35.3M |
| EBITDA Margin % | - | - | - | - | -2833.1% | - | - | - | - | - | -756.11% | - | - | - | - | - | - | - | -366.36% | - |
| EBITDA Growth % | -64.34% | -54.38% | -68.56% | -144.17% | 14.2% | -1.32% | -3.61% | 21.97% | 15.87% | 25.67% | 25.85% | 2.63% | -4.5% | 2.12% | -33.6% | 6.25% | -40.05% | -52.2% | -18.48% | -68.76% |
| D&A (Non-Cash Add-back) | 465K | 535K | 683K | 810K | 890K | 956K | 997K | 1.01M | 1.51M | 1.53M | 3.02M | 1.71M | 1.79M | 1.6M | 1.43M | 1.32M | 962K | 1.2M | 1.17M | 1.08M |
| EBIT | -47.65M | -49.85M | -48.22M | -62.22M | -29.22M | -32.9M | -29.2M | -26.16M | -34.53M | -33.06M | -29.04M | -33.94M | -41.04M | -44.02M | -38.13M | -34.42M | -38.52M | -44.54M | -28.64M | -36.38M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.2M | 0 | 0 | 0 | -80.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2M | 0 | 0 | 0 | 80.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -629K | 664K | 1.2M | 1.69M | 2.09M | 2.41M | 2.05M | 1.31M | 1.66M | 1.58M | 1.2M | 1.22M | 923K | 283K | 244K | 10K | 160K | 205K | 207K | -138K |
| Pretax Income | -47.65M | -49.19M | -47.02M | -60.53M | -27.13M | -30.5M | -27.15M | -24.85M | -32.87M | -31.49M | -29.04M | -32.72M | -40.11M | -43.74M | -37.89M | -34.41M | -38.36M | -44.33M | -28.44M | -36.52M |
| Pretax Margin % | - | - | - | - | -2713.4% | - | - | - | - | - | -806.64% | - | - | - | - | - | - | - | -379.15% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.13M | 17K | 21K | 17K | 19K | 17K | 19K | 19K | 0 | 0 | 0 | 0 | 1.11M |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4.56% | -0.05% | -0.07% | -0.06% | -0.06% | -0.04% | -0.04% | -0.05% | 0% | 0% | 0% | 0% | -3.05% |
| Net Income | -47.65M | -49.19M | -47.02M | -60.53M | -27.13M | -30.5M | -27.15M | -23.71M | -32.88M | -31.51M | -29.06M | -32.74M | -40.13M | -43.76M | -37.91M | -34.41M | -38.36M | -44.33M | -28.44M | -37.63M |
| Net Margin % | - | - | - | - | -2713.4% | - | - | - | - | - | -807.11% | - | - | - | - | - | - | - | -379.15% | - |
| Net Income Growth % | -75.62% | -61.29% | -73.2% | -155.25% | 17.49% | 3.21% | 6.57% | 27.56% | 18.06% | 28% | 23.35% | 4.86% | -4.61% | 1.29% | -33.31% | 8.56% | -38.15% | -51.83% | -24.14% | -98.85% |
| Net Income (Continuing) | -47.65M | -49.19M | -47.02M | -60.53M | -27.13M | -30.5M | -27.15M | -23.71M | -32.88M | -31.51M | -29.06M | -32.74M | -40.13M | -43.76M | -37.91M | -34.41M | -38.36M | -44.33M | -28.44M | -37.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.03 | -2.34 | -2.25 | -1.96 | -1.30 | -0.89 | -1.50 | -0.41 | -0.57 | -0.54 | -0.50 | -0.56 | -0.40 | -0.44 | -0.38 | -0.35 | -0.39 | -0.45 | -0.29 | -0.38 |
| EPS Growth % | -56.15% | -162.92% | -50% | -378.05% | -128.07% | -64.81% | -200% | 26.79% | -42.5% | -22.73% | -31.58% | -60% | -2.56% | 2.22% | -31.03% | 7.89% | -25.81% | -25% | 6.45% | -46.15% |
| EPS (Basic) | -2.03 | -2.34 | -2.25 | -1.96 | -1.30 | -0.89 | -1.50 | -0.41 | -0.57 | -0.54 | -0.50 | -0.56 | -0.40 | -0.44 | -0.38 | -0.35 | -0.39 | -0.45 | -0.29 | -0.39 |
| Diluted Shares Outstanding | 23.49M | 21.01M | 20.94M | 20.9M | 20.88M | 20.85M | 16.48M | 57.98M | 57.98M | 57.98M | 57.98M | 57.98M | 99.47M | 99M | 98.6M | 98.13M | 98.13M | 98.02M | 97.75M | 97.75M |
| Basic Shares Outstanding | 23.49M | 21.01M | 20.94M | 20.9M | 20.88M | 20.85M | 16.48M | 57.98M | 57.98M | 57.98M | 57.98M | 57.98M | 99.47M | 99M | 98.6M | 98.13M | 98.13M | 98.02M | 97.75M | 97.6M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |